These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1891483)

  • 1. Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.
    Möller HJ
    Pharmacopsychiatry; 1991 May; 24(3):71-5. PubMed ID: 1891483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not as golden as standards should be: interpretation of the Hamilton Rating Scale for Depression.
    Kriston L; von Wolff A
    J Affect Disord; 2011 Jan; 128(1-2):175-7. PubMed ID: 20696481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizability of antidepressant efficacy trials.
    Zimmerman M; Posternak MA; Chelminski I
    Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressant predictability: cartazolate.
    Sathananthan G; Mir P; Minn FL; Gershon S
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):475-8. PubMed ID: 816605
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxapine: a double-blind evaluation of antidepressant activity.
    Gallant DM; Swanson WC; Mielke DH; Guerrero-Figueroa R; Collins H
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):56-9. PubMed ID: 4632507
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.
    Katz MM; Bowden CL; Berman N; Frazer A
    J Clin Psychopharmacol; 2006 Dec; 26(6):549-53. PubMed ID: 17110809
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences.
    Hegerl U; Mergl R
    J Psychopharmacol; 2010 Apr; 24(4):445-8. PubMed ID: 19825901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?
    Mulsant BH; Houck PR; Gildengers AG; Andreescu C; Dew MA; Pollock BG; Miller MD; Stack JA; Mazumdar S; Reynolds CF
    J Clin Psychopharmacol; 2006 Apr; 26(2):113-20. PubMed ID: 16633138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment.
    Salvadorini F; Galeone F; Nicotera M; Ombrato M; Saba P
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):513-20. PubMed ID: 810312
    [No Abstract]   [Full Text] [Related]  

  • 13. [The relationship between the clinical effects of dibenzepin (Noveil) and its plasma concentration (author's transl)].
    Modestin J
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):29-38. PubMed ID: 4602372
    [No Abstract]   [Full Text] [Related]  

  • 14. [Basic problems in clinical testing of antidepressive drugs].
    Immich H; Eckmann F; Neumann H; Schäpperle O; Schwarz H; Tempel H
    Arzneimittelforschung; 1971 May; 21(5):644-9. PubMed ID: 4936794
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the use of behavioral rating scales in studies evaluating the efficacy of antianxiety and antidepressant drugs.
    Fankhauser MP; German ML
    Am J Hosp Pharm; 1987 Sep; 44(9):2087-100. PubMed ID: 2890299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales.
    Möller HJ; Müller H; Volz HP
    Pharmacopsychiatry; 1996 Mar; 29(2):57-62. PubMed ID: 8741022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidepressant properties of A-25794: a pilot study.
    Flemenbaum A; Schiele BC
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):53-6. PubMed ID: 4395300
    [No Abstract]   [Full Text] [Related]  

  • 18. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confounding influence of extraneous symptoms on clinical global impression ratings for depression.
    Targum SD; Busner J; Dunn J
    J Clin Psychopharmacol; 2008 Oct; 28(5):587-9. PubMed ID: 18794667
    [No Abstract]   [Full Text] [Related]  

  • 20. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.